These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34163251)

  • 1. microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction].
    Cancer Manag Res; 2021; 13():4765. PubMed ID: 34163251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-944 inhibits the malignancy of hepatocellular carcinoma by directly targeting IGF-1R and deactivating the PI3K/Akt signaling pathway.
    Lv L; Wang X; Ma T
    Cancer Manag Res; 2019; 11():2531-2543. PubMed ID: 31114322
    [No Abstract]   [Full Text] [Related]  

  • 3. microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R [Retraction].
    Am J Cancer Res; 2021; 11(9):4641. PubMed ID: 34659912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4937-4938. PubMed ID: 34611413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-877 Inhibits Malignant Progression of Colorectal Cancer by Directly Targeting MTDH and Regulating the PTEN/Akt Pathway [Retraction].
    Cancer Manag Res; 2021; 13():7489-7490. PubMed ID: 34611442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-Induced Aquaporin-3 Changes Hepatocellular Carcinoma Cell Sensitivity to Sorafenib by Activating the PI3K/Akt Signaling Pathway [Retraction].
    Cancer Manag Res; 2021; 13():9027-9028. PubMed ID: 34916846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4739-4740. PubMed ID: 34526778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-628 Inhibits the Proliferation of Acute Myeloid Leukemia Cells by Directly Targeting IGF-1R [Retraction].
    Onco Targets Ther; 2021; 14():4847-4848. PubMed ID: 34584423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Non-Coding RNA
    Cancer Manag Res; 2022; 14():399-400. PubMed ID: 35115836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-548b Suppresses Aggressive Phenotypes of Hepatocellular Carcinoma by Directly Targeting High-Mobility Group Box 1 mRNA [Retraction].
    Cancer Manag Res; 2021; 13():7593-7594. PubMed ID: 34675654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-936 Targets FGF2 to Inhibit Epithelial Ovarian Cancer Aggressiveness by Deactivating the PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4961-4962. PubMed ID: 34675537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction].
    Cancer Manag Res; 2021; 13():7245-7246. PubMed ID: 34566431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-26a Directly Targeting MMP14 and MMP16 Inhibits the Cancer Cell Proliferation, Migration and Invasion in Cutaneous Squamous Cell Carcinoma [Retraction].
    Cancer Manag Res; 2021; 13():7249-7250. PubMed ID: 34566433
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Cancer Manag Res; 2021; 13():7645-7646. PubMed ID: 34675660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of MicroRNA-130a Inhibits Oral Squamous Cell Carcinoma Proliferation and Metastasis via the Hippo-YAP Pathway [Retraction].
    Cancer Manag Res; 2021; 13():8005-8006. PubMed ID: 34707407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-876 is Sponged by Long Noncoding RNA LINC00707 and Directly Targets Metadherin to Inhibit Breast Cancer Malignancy [Retraction].
    Cancer Manag Res; 2021; 13():7243-7244. PubMed ID: 34566430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression by Targeting PDK1/PI3K/AKT Pathway [Retraction].
    Onco Targets Ther; 2023; 16():1023-1024. PubMed ID: 38090112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction: Down-regulation of HOXB5 inhibits TGF-β-induced migration and invasion in hepatocellular carcinoma cells
    Sun JP; Ge QX; Ren Z; Sun XF; Xie SP
    RSC Adv; 2022 Sep; 12(43):27996. PubMed ID: 36320248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retraction: Kannan et al. AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway.
    International Journal Of Molecular Sciences Editorial Office
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35708348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.